IL247325A0 - Therapeutic methods using noribogaine and related compounds - Google Patents

Therapeutic methods using noribogaine and related compounds

Info

Publication number
IL247325A0
IL247325A0 IL247325A IL24732516A IL247325A0 IL 247325 A0 IL247325 A0 IL 247325A0 IL 247325 A IL247325 A IL 247325A IL 24732516 A IL24732516 A IL 24732516A IL 247325 A0 IL247325 A0 IL 247325A0
Authority
IL
Israel
Prior art keywords
noribogaine
related compounds
therapeutic methods
methods employing
employing
Prior art date
Application number
IL247325A
Other languages
English (en)
Hebrew (he)
Original Assignee
Demerx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/019692 external-priority patent/WO2015126434A1/en
Priority claimed from US14/195,822 external-priority patent/US9345711B2/en
Priority claimed from US14/485,514 external-priority patent/US20150231147A1/en
Application filed by Demerx Inc filed Critical Demerx Inc
Publication of IL247325A0 publication Critical patent/IL247325A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL247325A 2014-02-18 2016-08-17 Therapeutic methods using noribogaine and related compounds IL247325A0 (en)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US201461941387P 2014-02-18 2014-02-18
US201461941390P 2014-02-18 2014-02-18
US201461945746P 2014-02-27 2014-02-27
PCT/US2014/019692 WO2015126434A1 (en) 2014-02-18 2014-02-28 Methods for acute and long-term treatment of drug addiction
US14/195,822 US9345711B2 (en) 2014-02-18 2014-03-03 Methods for acute and long-term treatment of drug addiction
US201461952731P 2014-03-13 2014-03-13
US201461952741P 2014-03-13 2014-03-13
US201461952727P 2014-03-13 2014-03-13
US201461952738P 2014-03-13 2014-03-13
US201461952744P 2014-03-13 2014-03-13
US201461952733P 2014-03-13 2014-03-13
US201462005855P 2014-05-30 2014-05-30
US201462005847P 2014-05-30 2014-05-30
US201462005841P 2014-05-30 2014-05-30
US201462005851P 2014-05-30 2014-05-30
US201462005858P 2014-05-30 2014-05-30
US14/292,632 US20150231146A1 (en) 2014-02-18 2014-05-30 Methods for acute and long-term treatment of drug addiction
US201462007346P 2014-06-03 2014-06-03
US201462024388P 2014-07-14 2014-07-14
US201462033538P 2014-08-05 2014-08-05
US201462035335P 2014-08-08 2014-08-08
US14/485,514 US20150231147A1 (en) 2014-02-18 2014-09-12 Methods for acute and long-term treatment of drug addiction
PCT/US2015/016186 WO2015126836A2 (en) 2014-02-18 2015-02-17 Therapeutic methods employing noribogaine and related compounds

Publications (1)

Publication Number Publication Date
IL247325A0 true IL247325A0 (en) 2016-09-29

Family

ID=53879225

Family Applications (1)

Application Number Title Priority Date Filing Date
IL247325A IL247325A0 (en) 2014-02-18 2016-08-17 Therapeutic methods using noribogaine and related compounds

Country Status (10)

Country Link
EP (1) EP3107546A4 (zh)
JP (1) JP2017506244A (zh)
KR (1) KR20160124829A (zh)
CN (1) CN106413718A (zh)
AU (2) AU2015219172A1 (zh)
CA (2) CA2977636C (zh)
EA (1) EA201691656A2 (zh)
IL (1) IL247325A0 (zh)
TW (1) TW201534306A (zh)
WO (1) WO2015126836A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2942638A1 (en) 2013-03-15 2014-09-18 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone
US9561232B2 (en) 2014-02-18 2017-02-07 Demerx, Inc. Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use
US9591978B2 (en) 2014-03-13 2017-03-14 Demerx, Inc. Methods and compositions for pre-screening patients for treatment with noribogaine
US9549935B2 (en) 2014-07-14 2017-01-24 Demerx, Inc. Methods and compositions for treating migraines using noribogaine
WO2016086194A1 (en) 2014-11-26 2016-06-02 Demerx, Inc. Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT804200E (pt) * 1994-07-25 2006-09-29 Nda Int Inc Uso de derivados de noribogaina para tratamento de dependencia quimica em mamiferos
ES2435722T3 (es) * 1997-09-04 2013-12-23 Demerx, Inc. Noribogaína en el tratamiento del dolor y de la adicción a drogas
US7220737B1 (en) * 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
US20030153552A1 (en) * 2002-02-14 2003-08-14 Mash Deborah C. Method of treating chemical dependency in mammals and a composition therefor
WO2012012764A1 (en) * 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
CA2942638A1 (en) * 2013-03-15 2014-09-18 Demerx, Inc. Method for noribogaine treatment of addiction in patients on methadone

Also Published As

Publication number Publication date
CA2977636A1 (en) 2015-08-27
CA3221251A1 (en) 2015-08-27
TW201534306A (zh) 2015-09-16
EP3107546A2 (en) 2016-12-28
JP2017506244A (ja) 2017-03-02
AU2015219172A1 (en) 2016-09-29
AU2020267217A1 (en) 2020-12-03
EP3107546A4 (en) 2017-10-25
AU2020267217B2 (en) 2022-04-07
CA2977636C (en) 2024-01-02
EA201691656A2 (ru) 2017-03-31
CN106413718A (zh) 2017-02-15
WO2015126836A2 (en) 2015-08-27
KR20160124829A (ko) 2016-10-28

Similar Documents

Publication Publication Date Title
IL258931A (en) Medicinal compounds and methods
HK1243073A1 (zh) 治療性化合物及其用途
IL250685A0 (en) Medicinal substance induces cytotoxicity
HUE051354T2 (hu) Terapeutikum
FI3215147T3 (fi) Hermostoa salpaavia norketamiiniyhdisteitä ja -menetelmiä
GB201403093D0 (en) Therapeutic compounds and their use
IL250387A0 (en) combined treatment
GB201404470D0 (en) Therapeutic methods and materials
GB201415569D0 (en) Therapeutic Compounds
GB201410816D0 (en) Therapeutic agents
GB201405033D0 (en) Combination therapy
ZA201702522B (en) Combination therapy
GB201410216D0 (en) Therapeutic
HK1243342A1 (zh) 化合物和方法
GB201410815D0 (en) Therapeutic agents
IL247325A0 (en) Therapeutic methods using noribogaine and related compounds
GB201510637D0 (en) Therapeutic
GB201416273D0 (en) Therapeutic compounds
ZA201608217B (en) Combination therapy
GB201418508D0 (en) Therapeutic
GB201413719D0 (en) Therapeutic
GB201417777D0 (en) Novel compounds and therapeutic uses thereof
GB201410832D0 (en) Therapeutic
GB201410334D0 (en) Therapeutic
GB201410387D0 (en) Compounds and their therapeutic use